Tokyo, Japan

Yasuhiro Shiina

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2002-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Yasuhiro Shiina: Innovator in Pharmaceutical Chemistry

Introduction

Yasuhiro Shiina is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tetrahydroisoquinoline derivatives. With a total of 6 patents to his name, Shiina's research focuses on developing compounds that can be utilized in treating various neuromuscular and central nervous system disorders.

Latest Patents

Shiina's latest patents involve novel tetrahydroisoquinoline derivative compounds. These compounds are disclosed as potential active ingredients for pharmaceutical compositions aimed at preventing or treating diseases responsive to the modulation of skeletal sarcomere contractility. The modulation can be achieved through the troponin complex of fast skeletal muscle sarcomeres, involving components such as fast skeletal myosin, actin, tropomyosin, troponin C, troponin I, and troponin T. The applications of these compounds include treating neuromuscular disorders, voluntary muscle disorders, CNS disorders characterized by muscle weakness and fatigue, systemic disorder-related muscle symptoms, and dysfunctions of pelvic floor and urethral/anal sphincter muscles.

Career Highlights

Throughout his career, Yasuhiro Shiina has worked with notable companies in the pharmaceutical industry, including Cytokinetics, Inc. and Astellas Pharma GmbH. His work has been instrumental in advancing the understanding and treatment of various muscle-related conditions.

Collaborations

Shiina has collaborated with esteemed colleagues such as Ippei Sato and Takashi Kamikubo, contributing to the innovative research and development of pharmaceutical solutions.

Conclusion

Yasuhiro Shiina's contributions to pharmaceutical chemistry, particularly through his patents on tetrahydroisoquinoline derivatives, highlight his role as a key innovator in the field. His work continues to pave the way for advancements in treating neuromuscular and CNS disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…